During the last session, Zenas Biopharma Inc (NASDAQ:ZBIO)’s traded shares were 0.79 million. At the end of the trading day, the stock’s price was $12.00, reflecting an intraday gain of 14.94% or $1.56. The 52-week high for the ZBIO share is $26.25, that puts it down -118.75 from that peak though still a striking 16.25% gain since the share price plummeted to a 52-week low of $10.05. The company’s market capitalization is $501.49M, and the average intraday trading volume over the past 10 days was 0.18 million shares, and the average trade volume was 187.01K shares over the past three months.
Zenas Biopharma Inc (NASDAQ:ZBIO) trade information
Zenas Biopharma Inc (ZBIO) registered a 14.94% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 14.94% in intraday trading to $12.00, hitting a weekly high. The stock’s 5-day price performance is -29.87%, and it has moved by -48.70% in 30 days. The short interest in Zenas Biopharma Inc (NASDAQ:ZBIO) is 0.64 million shares and it means that shorts have 4.02 day(s) to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The consensus price target of analysts on Wall Street is $35, which implies an increase of 65.71% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $35 and $35 respectively. As a result, ZBIO is trading at a discount of -191.67% off the target high and -191.67% off the low.
ZBIO Dividends
Zenas Biopharma Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Also, the Mutual Funds coming in first place with the largest holdings of Zenas Biopharma Inc (ZBIO) shares are Fidelity Select Portfolios – Biotechnology and Fidelity Growth Company Fund . Data provided on Sep 30, 2024 indicates that Fidelity Select Portfolios – Biotechnology owns about 322.7 shares. This amounts to just over 0.77 percent of the company’s overall shares, with a $3.87 million market value. The same data shows that the other fund manager holds slightly less at 301.9, or about 0.72% of the stock, which is worth about $3.62 million.
